Finance

Lists
Why is 314130 down ၃.၈၂%?
Dive Deeper
314130:KOSDAQ
Genome&Company Inc
၃,၁၅၀.၀၀ ₩
-၃.၈၂%
(-၁၂၅.၀၀) 1D
နို ၁၃, GMT+၉ ၁၅:၃၀:၂၆  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 314130...
Open
၃,၂၆၀ ₩
High
၃,၄၃၅ ₩
Low
၃,၁၃၅ ₩
Mkt. cap
ဋေ ၁.၆၉ သ
Avg. vol.
၄.၀၈ သိန်း
Volume
၂.၃၀ သိန်း
52-wk high
၁၀,၁၈၀ ₩
52-wk low
၂,၇၄၅ ₩
EPS
-၉၆၅ ₩
Shares outstanding
၅.၃၇ ကုဋေ
No. of employees
၉၆
Open
၃,၂၆၀ ₩
High
၃,၄၃၅ ₩
Low
၃,၁၃၅ ₩
Mkt. cap
ဋေ ၁.၆၉ သ
Avg. vol.
၄.၀၈ သိန်း
Volume
၂.၃၀ သိန်း
52-wk high
၁၀,၁၈၀ ₩
52-wk low
၂,၇၄၅ ₩
EPS
-၉၆၅ ₩
Shares outstanding
၅.၃၇ ကုဋေ
No. of employees
၉၆
News stories
From web sources and news partners
ACROFAN USA
ACROFAN USA
·
ပြီးခဲ့သည့် ၅၁ မိနစ်
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
Reuters
Reuters
·
ပြီးခဲ့သည့် ၅၀ မိနစ်
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Wall Street Divided on S&P 500: Which ETFs Could Benefit in 2027?
About Genome&Company Inc
CEOHong Yoo Seok
Employees၉၆
Founded၂၀၁၅
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၆၅၅.၇၆ ဋေ
၅၈၆.၇၀ ဋေ
၅၇၈.၂၄ ဋေ
၆၂၅.၃၇ ဋေ
Cost of goods sold
၃၃၀.၈၄ ဋေ
၂၇၁.၅၅ ဋေ
၂၄၇.၂၉ ဋေ
၂၆၃.၂၇ ဋေ
Cost of revenue
၃၃၀.၈၄ ဋေ
၂၇၁.၅၅ ဋေ
၂၄၇.၂၉ ဋေ
၂၆၃.၂၇ ဋေ
Research and development expenses
၃၁၆.၂၅ ဋေ
၂၈၂.၃၀ ဋေ
၂၀၆.၄၇ ဋေ
၃၆၅.၇၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇၀၂.၄၀ ဋေ
၇၀၄.၅၂ ဋေ
၆၃၇.၉၃ ဋေ
၆၉၅.၇၉ ဋေ
Operating expense
ဋေ ၁.၁၃ ထ
ဋေ ၁.၀၂ ထ
၉၄၀.၅၃ ဋေ
ဋေ ၁.၁၆ ထ
Total operating expenses
ဋေ ၁.၄၆ ထ
ဋေ ၁.၂၉ ထ
ဋေ ၁.၁၉ ထ
ဋေ ၁.၄၂ ထ
Operating income
-၈၀၈.၉၇ ဋေ
-၇၀၃.၀၁ ဋေ
-၆၀၉.၅၈ ဋေ
-၇၉၇.၃၇ ဋေ
Other non operating income
၁.၈၃ သန်း
ဋေ ၂.၈၂ ထ
၅.၁၆ သန်း
-ဋေ ၃.၉၈ ထ
EBT including unusual items
-၈၃၂.၅၃ ဋေ
ဋေ ၁.၃၉ ထ
-၇၁၆.၄၈ ဋေ
-ဋေ ၄.၃၀ ထ
EBT excluding unusual items
-၈၂၉.၀၂ ဋေ
ဋေ ၂.၀၀ ထ
-၆၄၄.၁၈ ဋေ
-ဋေ ၄.၂၈ ထ
Income tax expense
-၂၈.၁၅ ကုဋေ
-၃၇.၅၀ ကုဋေ
-၃၅.၃၈ ကုဋေ
-၃၈.၉၂ ကုဋေ
Effective tax rate
၃.၃၈%
-၂.၆၉%
၄.၉၄%
၀.၉၀%
Other operating expenses
-
-
-
-
Net income
-၇၅၂.၆၉ ဋေ
ဋေ ၁.၄၆ ထ
-၆၃၄.၈၃ ဋေ
-ဋေ ၄.၂၁ ထ
Net profit margin
-၁၁၄.၇၈%
၂၄၈.၉၅%
-၁၀၉.၇၉%
-၆၇၃.၀၇%
Earnings per share
-
-
-
-
Interest and investment income
၂၄.၈၁ ကုဋေ
၂၀.၈၉ ကုဋေ
၂၄.၀၆ ကုဋေ
၁၂.၂၇ ကုဋေ
Interest expense
-၉၉.၀၇ ကုဋေ
-၁၂၈.၈၇ ဋေ
-၇၃.၂၃ ကုဋေ
-၁၁၇.၂၈ ဋေ
Net interest expenses
-၇၄.၂၇ ကုဋေ
-၁၀၇.၉၈ ဋေ
-၄၉.၁၇ ကုဋေ
-၁၀၅.၀၁ ဋေ
Depreciation and amortization charges
၄၃.၅၂ ကုဋေ
၃၁.၃၃ ကုဋေ
၄၂.၆၇ ကုဋေ
၄၄.၇၈ ကုဋေ
EBITDA
-၆၂၃.၁၆ ဋေ
-၆၀၄.၆၆ ဋေ
-၄၄၈.၇၄ ဋေ
-၆၄၀.၃၄ ဋေ
Gain or loss from assets sale
၃.၅၁ ကုဋေ
၄.၁၈ ကုဋေ
၂.၀၀ ကုဋေ
-၆၀၇.၅၉ ဋေ
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ